Professor Bernard Lerer on 'Pharmacogenetics of Antipsychotic Drug Treatment'

Professor Bernard Lerer gives this lecture entitled Pharmacogenetics of Antipsychotic Drug Treatment: From Man to Mouse to Clinical Diagnosis' at The Australian National University on 17 August 2010. This Public Lecture was held in conjunction with The Bootes Course on Translational Medicine: The Pathway from Discovery to Healthcare at the University's John Curtin School of Medical Research.

Professor Bernard Lerer served as the Director of the National Institute for Psychobiology in Israel from 1994-2002, after directing the Hadassah Biological Psychiatry Laboratory. Professor Lerer is currently a Professor of Psychiatry at the Hebrew University - Hadassah Medical School, as well as Editor-in-Chief of the International Journal of Neuropsychopharmacology.

Professor Lerer's main research interests are the molecular genetic basis of major psychiatric disorders, particularly schizophrenia, psychopharmacogenetics, the neurochemical mechanisms of action of antidepressants and electroconvulsive therapy (ECT), long term neurobiological effects of early life stress, and the clinical optimization of ECT. Professor Lerer is a Past Chairman of the Israel Society for Biological Psychiatry. He was elected to the American College of Neuropsychopharmacology in 1996 and has been Visiting Professor at the Universities of Cape Town, Copenhagen, and Hiroshima. Professor Lerer has published more than 250 research papers and has edited two books.

Category:

Education

Tags:

• Pharmacogenetics
• Antipsychotic Drug
• clinical
• diagnosis
• mental health
• healthcare
• JCSMR
• medical research
• science
• Bernard Lerer
• pharmacology
• schizophrenia
• neurochemistry
• anti depressants
• antidepressants
• ANU
• The ANU
• canberra
• education